EDAP TMS S.A. (EDAP)

NASDAQ: EDAP · IEX Real-Time Price · USD
8.25
+0.13 (1.66%)
Sep 30, 2022 4:00 PM EDT - Market closed
1.66%
Market Cap 298.20M
Revenue (ttm) 53.22M
Net Income (ttm) 2.67M
Shares Out 36.15M
EPS (ttm) 0.06
PE Ratio 137.50
Forward PE 38.02
Dividend n/a
Ex-Dividend Date n/a
Volume 54,583
Open 8.05
Previous Close 8.12
Day's Range 8.05 - 8.37
52-Week Range 5.00 - 8.99
Beta 1.25
Analysts Buy
Price Target 11.56 (+40.1%)
Earnings Date Nov 15, 2022

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological an... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jul 31, 1997
Employees 227
Stock Exchange NASDAQ
Ticker Symbol EDAP
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is 11.56, which is an increase of 40.12% from the latest price.

Price Target
$11.56
(40.12% upside)
Analyst Consensus: Buy
Stock Forecasts

News

EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?

EDAP TMS S.A. (EDAP) saw its shares surge in the last session with trading volume being higher than average.

5 days ago - Zacks Investment Research

EDAP TMS Hosting Urology Expert Panel and Live Focal One® Technology Demonstration

September 29, 2022 @ 8 AM ET Langham Hotel, NYC

6 days ago - GlobeNewsWire

EDAP Announces Pricing of Public Offering of American Depositary Shares

LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its public offering of its American Depos...

1 week ago - GlobeNewsWire

EDAP Announces Proposed Public Offering of American Depositary Shares

LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that it has commenced a public offering of its Americ...

1 week ago - GlobeNewsWire

Is EDAP TMS (EDAP) Outperforming Other Medical Stocks This Year?

Here is how EDAP TMS S.A. (EDAP) and Indivior PLC (INVVY) have performed compared to their sector so far this year.

1 month ago - Zacks Investment Research

Here's Why Momentum in EDAP TMS S.A. (EDAP) Should Keep going

EDAP TMS S.A. (EDAP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks.

1 month ago - Zacks Investment Research

EDAP Reports Second Quarter 2022 Results

LYON, France, August 24, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the second quarter 2022.

1 month ago - GlobeNewsWire

EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022

Company to host conference call and webcast on Thursday , August 25 th at 8:30 am EDT

1 month ago - GlobeNewsWire

Here's Why "Trend" Investors Would Love Betting on EDAP TMS S.A. (EDAP)

EDAP TMS S.A. (EDAP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks.

2 months ago - Zacks Investment Research

Strength Seen in EDAP TMS S.A. (EDAP): Can Its 13.4% Jump Turn into More Strength?

EDAP TMS S.A. (EDAP) witnessed a jump in share price last session on above-average trading volume.

2 months ago - Zacks Investment Research

EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment S...

Proposed rule, if adopted for CY23 , would increase Medicare Payment for a Focal One HIFU procedure completed on an outpatient basis at a hospital

2 months ago - GlobeNewsWire

Has EDAP TMS (EDAP) Outpaced Other Medical Stocks This Year?

Here is how EDAP TMS S.A. (EDAP) and Fstar Therapeutics, Inc. (FSTX) have performed compared to their sector so far this year.

2 months ago - Zacks Investment Research

EDAP's Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses

LYON, France, June 28, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced its participation to two major forthcoming international r...

3 months ago - GlobeNewsWire

EDAP Announces Multiple Oral Presentations at the 21st International Symposium on Therapeutic Ultrasound

LYON, France, June 6, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that three oral presentations will be delivered on its HIFU...

3 months ago - GlobeNewsWire

EDAP Reports First Quarter 2022 Results

LYON, France, May 17, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the first quarter 2022.

4 months ago - GlobeNewsWire

EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022

Company to host conference call and webcast on , Wednesday, May 18 th at 8:30 am EDT

4 months ago - GlobeNewsWire

EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)

LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will be showcasing and exhibiting its Focal...

4 months ago - GlobeNewsWire

EDAP Provides Corporate Update on US Focal One® Installation Growth

Company announces Focal One® placements at three renowned academic institutions in March

5 months ago - GlobeNewsWire

EDAP Reports Fourth Quarter and Full Year 2021 Results

LYON, France, March 30, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full...

6 months ago - GlobeNewsWire

EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022

Company to host conference call and webcast on Thursday, March 31 , at 8:30 am ET

6 months ago - GlobeNewsWire

EDAP Issues Letter to Shareholders

LYON, France, February 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders:

8 months ago - GlobeNewsWire

EDAP Provides Corporate Update on US Focal One Installation Growth

Company announces s everal k ey U.S. Focal One installations during Q4

8 months ago - GlobeNewsWire

EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat a...

10 months ago - GlobeNewsWire

EDAP Reports Third Quarter 2021 Results and Provides Operational Update

LYON, France, November 17, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the third quarter of 202...

10 months ago - GlobeNewsWire

EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021

Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET

10 months ago - GlobeNewsWire